Lanreotide Subcutaneous and Novoseven
Determining the interaction of Lanreotide Subcutaneous and Novoseven and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: NovoSeven RT with MixPro (injection), NovoSeven RT
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanreotide Subcutaneous-NovoSeven RT
- Lanreotide Subcutaneous-NovoSeven RT with MixPro injection
- Lanreotide Subcutaneous-Novothyrox
- Lanreotide Subcutaneous-Noxafil
- Lanreotide Subcutaneous-Noxafil (Posaconazole Delayed-Release Tablets)
- Lanreotide Subcutaneous-Noxafil (Posaconazole Injection)
- Novoseven-Lansoprazole
- Novoseven-Lansoprazole Delayed-Release Capsules
- Novoseven-Lansoprazole Orally Disintegrating Tablets
- Novoseven-Lansoprazole, Amoxicillin, and Clarithromycin
- Novoseven-Lanthanum
- Novoseven-Lanthanum carbonate